Results:
The five-year infection-free prosthetic survival rate was 68.5% (95% confidence interval [CI] = 59.2% to 79.3%) for the antibiotic-suppression group and 41.1% (95% CI = 34.9% to 48.5%) for the non-suppression group (hazard ratio [HR] = 0.63, p = 0.008). Stratification by the type of surgery and the infecting organism showed a higher five-year survival rate for the patients in the suppression group who underwent irrigation and debridement with polyethylene exchange (64.7%) compared with those in the non-suppression group who underwent irrigation and debridement with polyethylene exchange (30.4%, p < 0.0001) and a higher five-year survival rate for the patients in the suppression group who had a Staphylococcus aureus infection (57.4%) compared with those in the non-suppression group who had a Staphylococcus aureus infection (40.1%, p = 0.047).
Conclusions: Chronic suppression with oral antibiotics increased the infection-free prosthetic survival rate following surgical treatment for periprosthetic joint infection. Patients who underwent irrigation and debridement with polyethylene exchange and those who had a Staphylococcus aureus infection had the greatest benefit.
Level of Evidence: Therapeutic Level III. See the Instructions for Authors for a complete description of levels of evidence. P eriprosthetic joint infection is a devastating complication of total knee and hip arthroplasty that is associated with substantial morbidity 1, 2 , mortality 3 , and economic burden 4, 5 . The risk of infection following total joint arthroplasty is approximately 1% 4, 6, 7 . Treatment guidelines for periprosthetic joint infection recommend irrigation and debridement with polyethylene exchange for acute infections caused by low-virulence pathogens around well-fixed implants and two-stage revision Disclosure: None of the authors received payments or services, either directly or indirectly (i.e., via his or her institution), from a third party in support of any aspect of this work. One or more of the authors, or his or her institution, has had a financial relationship, in the thirty-six months prior to submission of this work, with an entity in the biomedical arena that could be perceived to influence or have the potential to influence what is written in this work. No author has had any other relationships, or has engaged in any other activities, that could be perceived to influence or have the potential to influence what is written in this work. The complete Disclosures of Potential Conflicts of Interest submitted by authors are always provided with the online version of the article.
for infections that are chronic, caused by a high-virulence pathogen, or around a loose component 8 . A two to six-week postoperative course of pathogen-specific intravenous antibiotic therapy is also recommended in both cases 9 . Despite optimal surgical and medical treatments, failure rates are still high, with five-year prosthetic survival rates ranging from 38.4% 10 to 64.7% 11 . Chronic antibiotic suppression is an unproven method that has been used in an attempt to increase the chance of retaining a functional prosthesis in certain patients, typically those who have undergone surgical treatment for periprosthetic joint infection but have a high risk of relapse and/or for whom the next surgical step would be limb-threatening. There are no clearly defined criteria for increased risk of relapse, although common factors include a history of multiple joint infections, immunosuppression, comorbidities that predispose to periprosthetic joint infection, and a virulent pathogen 9, 12 . Candidates for chronic antibiotic suppression must also have the ability to tolerate sideeffects.
The purpose of this study was to evaluate patients who underwent irrigation and debridement with polyethylene exchange or two-stage revision in order to (1) compare infectionfree prosthetic survivorship between patients who did and those who did not undergo subsequent chronic oral antibiotic suppression; (2) analyze infection-free survivorship stratified by the type of surgery, infecting organism, and involved joint; and (3) determine factors associated with failure of chronic suppression with oral antibiotics and build a nomogram to preoperatively predict the probability of failure.
Materials and Methods
A fter institutional review board approval was obtained, we used a combination of Current Procedural Terminology (CPT)-4 and International Classification of Diseases, Ninth Revision (ICD-9) codes to identify all revision total knee and hip arthroplasties performed from 1996 to 2010 at a single institution. Of 10,411 procedures that were identified, 7111 that were done for indications other than periprosthetic joint infection, 2510 that were not either an irrigation and debridement with polyethylene exchange or a complete two-stage revision, and 135 that were done for a condition that did not fulfill the criteria for periprosthetic joint infection 12 were excluded. This left 655 eligible procedures in 625 patients for the study (Fig. 1) . Of the 655 procedures, 379 were two-stage revisions (240 knees and 139 hips) and 276 were irrigation and debridement procedures with polyethylene exchange (207 knees and sixty-nine hips). Chart review and obituary database searches were performed. All cases were comanaged with the infectious diseases service at our hospital. Patients received broad-spectrum intravenous antibiotics following the first stage of the two-stage revision or following irrigation and debridement with polyethylene exchange. An organism-specific antibiotic regimen was started after culture results were obtained. One hundred and twenty patients received chronic antibiotic suppression, defined as treatment with oral antibiotics for a minimum of six months following the initial course of intravenous antibiotics. As we are aware of no current specific indication for chronic antibiotic suppression, the decision of whether to offer this treatment was individualized. Patients with intraoperative cultures that were positive for virulent pathogens received antibiotic suppression if they had a risk factor for reinfection (a history of multiple joint infections, previous failed surgery for periprosthetic joint infection, retained implants and/or immunosuppression). Patients with less virulent pathogens or negative cultures received antibiotic suppression if they had multiple risk factors for reinfection. The patients were contacted by telephone and questioned regarding compliance with the antibiotic therapy, additional joint surgery, joint pain, and drainage. Outcomes and death rates were recorded. Exclusion criteria included non-compliance (n = 9), less than one year of followup (n = 12), and initiation of oral antibiotic therapy after the onset of new drainage (n = 7). This resulted in ninety-two patients eligible for the study.
The non-suppression group was selected from the remaining pool of 505 patients in whom a total of 535 periprosthetic joint infections had been managed without chronic antibiotic suppression. In an effort to manage the inherent selection bias, the suppression-group patients were matched with similar, non-suppressiongroup patients. Propensity score matching was used for age, sex, body mass index (BMI), Charlson comorbidity index, number of previous operations on the affected joint, affected joint (hip or knee), type of surgery (irrigation and debridement with polyethylene exchange versus two-stage revision) preceding the antibiotic suppression, and infecting organism (Staphylococcus aureus versus non-S. aureus). Although the Charlson comorbidity index was developed to predict mortality within one year after hospital admission 13, 14 , it has been shown to be an independent predictor of periprosthetic joint infection in both the hip 15 and the knee 16 . Propensity scores were estimated on the scale of the log-odds based on the above variables with use of a logistic regression model. Patients in the suppression group were matched to those in the non-suppression group with the closest propensity scores without replacement in a ratio of 1:3 (suppression:non-suppression). The covariate balance resulting from propensity score matching was checked with use of standardized differences, variance ratios of propensity scores, and variance ratios of residuals orthogonal to propensity scores for each covariate. Balance was found to be adequate without restricting which patients were matched by enforcing a matching caliper.
The primary outcome variable was infection-free prosthetic survival, with additional surgery due to infection or death as the end points. All patients were included in the analysis even if the time to the outcome was less than one year. Further stratification on the basis of the affected joint, type of index surgery, and infecting organism was performed. Treatment failure was the outcome variable used to compare the patients in the suppression group for whom the Flowchart showing eligible cases of chronic antibiotic suppression and matched cases without suppression. I&D = irrigation and debridement, PJI = periprosthetic joint infection, SA = S. aureus, and C.I. = comorbidity index.
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T Oxacillin 2 g qid or q4h (14) Vancomycin 1 or 1.5 or 2 g bid or qd or q48h (8) Cefazolin 1 or 2 g tid (4) Imipenem 500 mg qid (1) Daptomycin 500 mg qd (1) Ceftriaxone 2 g qd (1) Ampicillin/sulbactam 2/1 g qid (1) Clindamycin 900 mg tid (1) Piperacillin/tazobactam 3/0.375 g tid (1) Dicloxacillin 500 mg qid or tid or bid (11) Doxycycline 100 mg qid or bid or qd (7) Cephalexin 500 mg qid or tid or bid (6) Trimethoprim/sulfamethoxazole 160/800 mg bid (5) Minocycline 100 mg qd (1) Amoxicillin 500 mg tid (1) Clindamycin 300 mg bid (1) Methicillin-resistant coagulase-negative staphylococci (21) Vancomycin 1 or 1.25 or 1.5 g bid or qd (14) Daptomycin 500 or 650 mg qd (3) Oxacillin 2 g qid (1) Clindamycin 600 mg tid (1) Linezolid 600 mg bid (1) Tigecycline 50 mg bid (1) Doxycycline 100 mg bid or qd (12) Rifampin 300 mg bid (2) Trimethoprim/sulfamethoxazole 160/800 mg bid or qd (4) Clindamycin 300 mg bid (2) Dicloxacillin 500 mg qid (2) Cephalexin 250 mg bid (1) Methicillin-resistant Staphylococcus aureus (13) Vancomycin 1 or 1.25 or 1.5 g bid or qd (8) Daptomycin 350 or 500 mg qd (2) Oxacillin 2 g qid (1) Linezolid 600 mg bid (1) Doxycycline 100 mg bid (1) Doxycycline 100 mg qd (8) Trimethoprim/sulfamethoxazole 160/800 mg bid (3) Clindamycin 300 mg bid (1) Erythromycin 400 mg bid (1) Methicillin-sensitive coagulase-negative staphylococci ( Clindamycin 900 mg tid (1) Cefazolin 1 g tid (1) Amoxicillin 500 mg tid (2) Trimethoprim/sulfamethoxazole 160/800 mg bid (2) Moxifloxacin 400 mg qd (1) Doxycycline 100 mg bid (1) Group-B streptococci (3) Penicillin G 2 million U q4h (1) Ampicillin 2 g qid (1) Vancomycin 1 g bid (1) Amoxicillin 500 mg tid (2) Dicloxacillin 250 mg tid (1) Diphtheroid-like bacilli (2) Vancomycin 1 g bid [ciprofloxacin 500 mg bid (1) or rifampin 300 mg PO bid (1)] (2) Doxycycline 100 mg bid or qd (2) Enterobacteriaceae ( *IV = intravenously, PO = orally, qid = four times a day, q4h = every four hours, tid = three times a day, bid = twice a day, qd = every day, and q48h = every fortyeight hours. The number of pathogens adds up to more than the total number of ninety-two patients because some patients had polymicrobial infections. Also, the number of antibiotic regimens may add up to more than the total number of pathogens because some patients had multiple regimens at once. Oxacillin 2 g q4h or qid [rifampin 300 mg bid (9)] (25) Vancomycin 500 mg or 1 or 1.25 g bid or qd [rifampin 300 or 600 mg bid (2)] (16) Cefazolin 1 or 2 g bid or tid (9) Penicillin G 3 million U q4h [rifampin 300 mg bid (1)] (3) Daptomycin 600 mg qd (2) Piperacillin/tazobactam 3/0.375 g tid (1) Ceftriaxone 1 g qd (1) Amoxicillin 1 g tid (1) Linezolid 600 mg bid (1) Clindamycin 900 mg tid (1) Ampicillin/sulbactam 2/1 g qid (1) Doxycycline 100 mg bid (1) Methicillin-resistant Staphylococcus aureus (53)
Vancomycin 500 mg or 1 or 1.25 or 1.5 g bid or qd or q48h or q72h [rifampin 300 mg bid (14) *IV = intravenously, PO = orally, q4h = every four hours, qid = four times a day, bid = twice a day, qd = every day, tid = three times a day, q48h = every forty-eight hours, q72h = every seventy-two hours, and q8h = every eight hours. The number of pathogens adds up to more than the total number of 276 patients because some patients had polymicrobial infections. Also, the number of antibiotic regimens may add up to more than the total number of pathogens because some patients had multiple regimens at once.
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suppression failed with those for whom it did not fail. Failure was defined, as described by Diaz-Ledezma et al.
17
, as (1) subsequent surgical intervention for infection after the index procedure; (2) persistent fistula, drainage, or joint pain at the last follow-up visit; or (3) death related to the periprosthetic joint infection. Any unresolved drainage at the last follow-up visit was considered a failure. Pain was considered to indicate a failure only when it was severely debilitating and prevented any kind of walking at the time of the last follow-up. Because we could not determine the causes of most deaths, we considered death within one year after the surgery as the cutoff point for failure; this was based on the findings of Zmistowski et al. 3 , who showed that the highest differential mortality between septic and aseptic revisions occurred within one year.
The Fisher exact test or Pearson chi-square test was used for categorical data, whereas the Wilcoxon rank sum test or Welch two-sample t test was used for continuous data. Infection-free survival was estimated by using the Kaplan-Meier method. Hazard ratios (HRs) for comparison between the suppression and nonsuppression groups were calculated with use of Cox proportional hazards regression models, with adjustment for variables that were previously used for matching. Subset analyses were performed by selecting the matched groups in which all subjects belonged to the subset of interest. This was done to preserve the matching characteristics of the original data, and the propensity score balance was rechecked within these subsets to verify that this had been accomplished. A log-rank test was used to compare prosthetic survival between the suppression and non-suppression groups in the subset cohorts. Further modeling was performed with Cox proportional hazards models to verify the effect of chronic antibiotic therapy across the different subsets. This model compared the benefits of suppression between the subsets of infecting organism (methicillin-resistant S. aureus [MRSA] versus methicillin-sensitive S. aureus [MSSA] versus non-S. aureus), affected joint (hip versus knee), and type of surgery (irrigation and debridement with polyethylene exchange versus two-stage revision).
Failures within the suppression group were modeled as a function of clinically relevant variables, with use of a penalized logistic regression model 18 . As a result of a low ratio of events to parameters, this model included only three variables and used a ridge-type penalty to correct for possible overfitting. A significance level of 5% was used, and analyses were done with use of R software (version 3.0.2; R Foundation for Statistical Computing, Vienna, Austria). The penalized model was fit with use of rms (regression modeling strategies) in the R package 19 .
Source of Funding
This study was internally funded by our institution.
Results

T
he baseline characteristics of the suppression and nonsuppression groups are depicted in Table I .
The mean duration of follow-up (and standard deviation) was 69.1 ± 38.2 months (range, 2.2 to 168.3 months) in the suppression group and 41.6 ± 40.2 months (range, less than one to 183 months in the non-suppression group). Sixty-two (67.4%) of the patients in the suppression group and 186 (67.4%) of those in the non-suppression group had had previous revisions (mean, 2.7 ± 1.4 and 2.4 ± 1.7 previous revisions, respectively) for any cause. With the exception of two knees and one hip (all in the non-suppression group), which had a resection arthroplasty, all knees were treated with static spacers and all hips were treated with articulated spacers at the time of explantation. The time interval between removal and reimplantation was variable, averaging 21.1 ± 9.7 weeks (range, 6.6 to 46.3 weeks) in the suppression group and 15 ± 8 weeks (range, 3.1 to 45.6 weeks) in the non-suppression group. The median duration of postoperative intravenous therapy with antibiotics was six weeks in both groups. The mean duration of oral antibiotic suppression was 63.5 ± 38.3 months (range, six to 165.1 months). The specific antibiotic regimens are depicted in Tables II and III. The five-year infection-free prosthetic survival rate was 68.5% (95% confidence interval [CI] = 59.2% to 79.3%) for the antibiotic-suppression group compared with 41.1 % (95% CI = 34.9% to 48.5%) for the non-suppression group (HR = 0.63, p = 0.008) (Fig. 2) . The Cox proportional hazards model showed (Table IV) . Stratification by the type of index surgery showed that, in the group that underwent irrigation and debridement with polyethylene exchange, the patients treated with chronic antibiotic suppression had an increased five-year infection-free survival rate (64.7% [95% CI = 49.7% to 77.3%]) compared with the non-suppression group (30.4% [95% CI = 22.4% to 39.6%]; p < 0.0001). There was no difference in survival between the suppression and nonsuppression groups following two-stage revision (p = 0.14) (Fig. 3) . Kaplan-Meier infection-free prosthetic survival curves for subset cohorts. The blue line represents the suppression group, and the red line represents the non-suppression group; the shaded areas surrounding the lines represent the 95% CI. Fig. 3 -A Individuals who underwent irrigation and debridement with polyethylene exchange (p < 0.0001 for the difference between the suppression and non-suppression groups). Fig. 3 -B Individuals who underwent a two-stage revision (p = 0.14). Stratification by the affected joint showed a significant increase in the infection-free survival rate in the suppression group, compared with the non-suppression group, both after revision for a hip infection Stratification by the infecting organism showed that, when the pathogen was S. aureus, the five-year infection-free survival rate in the suppression group (57.4% [95% CI = 39.2% to 73.8%]) was increased compared with that in the non-suppression group (40.1% [95% CI = 29.6% to 51.6%]; p = 0.047). There was no difference in survival between the suppression and nonsuppression groups when the patients had a non-S. aureus infection (p = 0.62). The results of additional stratification, by whether the patient had MRSA, MSSA, or gram-negative infection, are shown in Figure 4 , although this analysis did not preserve the original matching quality between the suppression and non-suppression groups. The benefit of chronic antibiotic suppression compared across different subsets was non-significant for the entire model (p = 0.22) and at every interaction (Table V) .
Thirty-two patients (34.8%) in the suppression group and 115 (41.7%) in the non-suppression group met the criteria for failure of treatment. Comparisons between the patients for whom chronic antibiotic suppression failed and those for whom it did not fail are depicted in Table VI . Failures had a lower association with hip infection than with knee infection (HR = 0.10, p = 0.013) and were associated with a higher number of prior revisions (HR = 2.83, p = 0.026) (Table VII) . , strategies to avoid limbthreatening outcomes and high mortality rates associated with periprosthetic joint infection are needed. In the current study, we examined how chronic suppressive antibiotics affect infectionfree prosthetic survival rates after surgical intervention for periprosthetic joint infection. The five-year infection-free survival rate in the suppression group was 68.5% compared with 41.1% in the non-suppression group (p = 0.008). The increased survival rate in the suppression group is consistent with the findings in another study, which showed a three-year success rate of 78% after treatment of 112 periprosthetic joint infections with debridement, antibiotics, and implant retention 21 . Other studies documenting the management of periprosthetic joint infection with antibiotics and prosthesis retention have demonstrated both positive 22, 23 and negative 24 outcomes; however, subsequent chronic suppression with oral antibiotics was not consistently used.
Stratification by the type of surgery and infecting organism showed that the patients who benefited the most from chronic suppressive antibiotic therapy were those who underwent irrigation and debridement with polyethylene exchange and those with S. aureus infection. The benefit of suppression following irrigation and debridement with polyethylene exchange has already been documented and is in accordance with findings in the current literature [25] [26] [27] . Persistence of a latent infection is common Kaplan-Meier infection-free prosthetic survival curves for subsets with MRSA ( Fig. 4-A) , MSSA (Fig. 4-B) , and gram-negative (Fig. 4-C 
1229
T 5, 2015 in patients with retained implants and thus antibiotic suppression seems to be a reasonable alternative that avoids the need for a more invasive two-stage revision. Antibiotic suppression following two-stage procedures did not seem to affect prosthetic survival. The current study also showed that, among the patients who had S. aureus infection, those who underwent postoperative suppression had a higher infection-free survival rate than those who did not receive postoperative suppression.
This conflicts with the findings in the study by Brandt et al. 28 , in which suppression did not influence the outcome of surgical treatment of periprosthetic joint infections caused by S. aureus. Possible explanations for this discrepancy are the newer, more efficacious antibiotic regimens used in the present study, the longer course of intravenous antibiotics postoperatively (six weeks versus four weeks in the study by Brandt et al.) , and differences in the end points that were used. Furthermore, it has been suggested that S. aureus survives in the intracellular environment 29 , which may account for its higher recurrence rate and thus the need for a long-term oral antibiotic regimen. Finally, chronic antibiotic therapy did not seem to influence infection-free survival after revisions for non-S. aureus infections. This was probably due to the greater success attained with the surgery and by the increased susceptibility of these pathogens to intravenous agents used in the first six weeks after surgery. Numerous studies have shown the efficacy of chronic suppression even of non-S. aureus infections [25] [26] [27] , but the absence of a control group in those studies precludes any definite conclusions from being reached. The multivariate models constructed for our study confirmed the overall benefit of chronic antibiotic therapy. However, this analysis was not able to determine the subset from which this benefit was mostly derived, probably because of the limited number of events in each subset and overfitting of the data within the model.
The 34.8% failure rate for the ninety-two patients who received chronic antibiotic therapy for a minimum of six months was higher than the rates in the most recently published studies 25, 26 . Segreti et al. 25 reviewed the cases of eighteen patients who had undergone surgical debridement and six to eight weeks of intravenous antibiotics followed by prolonged antibiotic suppression. At five years, only three had persistent symptoms of infection. Rao et al. 26 prospectively examined thirty-six patients who had undergone the same protocol of surgical debridement and four to six weeks of intravenous antibiotics prior to antibiotic suppression. The failure rate was 13.9% (five of the thirty-six patients) after 4.4 years of follow-up. Possible explanations for the higher failure rates observed in the present study include the higher prevalence of invasive pathogens (47.8% of the infections were caused by S. aureus compared with 38.9% in the other studies 25, 26 ) and the inclusion of deaths within the first year after treatment as failures. Older studies on chronic antibiotic suppression 27, 30, 31 showed higher failure rates, probably as a result of less efficient antibiotic regimens (Table VIII) . In our study, patients for whom suppressive antibiotic treatment failed had had more prior joint revisions. The association of a higher number of previous revisions with increased failure rates is in accordance with the findings in other studies 32, 33 . We also found that patients with knee periprosthetic joint infection had a higher rate of failure than those with hip infection. In a review of 9245 cases, Pulido et al. 6 reported an increased prevalence of periprosthetic joint infection after total knee arthroplasty than after total hip arthroplasty. This does not explain why knees have an inferior response to treatment of periprosthetic joint infection, but it provides some evidence of an increased susceptibility to periprosthetic joint infection in knees.
Our study was limited by its sample size. This is a common limitation of studies of chronic antibiotic suppression for periprosthetic joint infection because it is a last-resort treatment for an infrequent complication of joint arthroplasty. The small sample size compromised the ability of the multivariate analyses stratified by the infecting organism, affected joint, and type of surgery to provide results similar to those in the survivorship analysis. In addition, sampling bias was an inherent limitation of our study when the suppression group was compared with the non-suppression group. In an effort to overcome this bias, propensity score matching with a 3:1 matching ratio was done for eight variables. Also, the retrospective nature of the study precluded the use of standardized surgical techniques and antibiotic regimens. Finally, the six subset cohorts had lower-quality propensity score matching than the cohort as a whole. This was the case because the matching was designed to produce good matches for all subjects rather than within subsets.
In summary, chronic suppression with oral antibiotics resulted in superior infection-free survival rates after surgical treatment for periprosthetic joint infection compared with those observed without suppression. Patients who underwent irrigation and debridement with polyethylene exchange and those with S. aureus infection showed the greatest benefit. Knee infection and a greater number of prior revisions were identified as variables associated with treatment failure. n
